World Orphan Drug Alliance (WODA) is an international consortium of pharmaceutical companies, established with the mission of improving patient access to new treatments for rare and debilitating diseases.
WODA operates by identifying biotech and pharmaceutical companies with novel therapies for rare and debilitating diseases, which may not yet be available to patients in many regions. It provides these companies with the opportunity to commercialize their innovative products in member countries through WODA's multi-territorial platform.
WODA’s commercial presence spans 158 markets, covered by 12 like-minded pharmaceutical companies, enabling an extensive global outreach while maintaining a strong local focus.
Each WODA member is an experienced and high-performance commercialization company, specializing in their own region and offering comprehensive support that ranges from named patient programs to full commercialization.
Regions covered by WODA members:
• African Subcontinet (Veld Pharmaceuticals)
• Australia, New Zealand, South East Asia (Specialised Therapeutics)
• Canada (Theratechnologies)
• Central and Eastern Europe (Medis)
• Greater China region (Healthmount)
• Greece, Cyprus, Malta (Path Pharma)
• Israel (CTS)
• Japan and South Korea (Nxera Pharma)
• Middle East, North Africa & Turkey (Vector Pharma)
• Latin America (iMedicines Group)
• Russia & the CIS region (Orpharm)
• Switzerland (EffRx Pharmaceuticals)
WODA partner for global access, pricing and commercialization strategies is Decisive Consulting.
WODA’s value to pharmaceutical & biotech companies with rare disease and specialty portfolio:
• Single point of contact for 158 countries
• Access to 210 million potential rare disease patients
• Full-service solution
• Deep understanding of local healthcare systems
• Flexible approach, tailored to the needs of partners and products
More about WODA: www.woda-alliance.com
Get in touch with us: partners@woda-alliance.com
Company Details
- Founded
- -
- Address
- New Jersey, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.woda-alliance.com/
- Keywords
- orphandrugs, rarediseases, distribution, oncology, CEE, Russia, LATAM, Switzerland, Middle East, Turkey, Japan, South Korea, African Subcontinent, Greater China, specialty medicines, Australia, New Zealand, South East Asia, market access, specialty medicines, Canada.
- HQ
- New Jersey
World Orphan Drug Alliance (Woda) Questions
World Orphan Drug Alliance (Woda)'s website is https://www.woda-alliance.com/
World Orphan Drug Alliance (Woda)'s LinkedIn profile is https://www.linkedin.com/company/woda-alliance
World Orphan Drug Alliance (Woda)'s industry is
Biotechnology Research
World Orphan Drug Alliance (Woda)'s top competitors are
Mink Therapeutics,
Innovative Medicines Group,
Orpharm Llc,
Eurordis-Rare Diseases Europe,
Veld Pharmaceuticals Gmbh,
Path Pharma Gmbh,
The Pharmaceutical Research And Manufacturers Association In The Gulf (Phrmag),
Medis,
Vector Pharma Fzco,
World Orphan Drug Congress.
World Orphan Drug Alliance (Woda)'s categories are Biotechnology Research
World Orphan Drug Alliance (Woda)'s founding year is 2022
